Financhill
Back

Cadrenal Therapeutics Stock Predictions

Cadrenal Therapeutics Stock Forecast

  • Is Cadrenal Therapeutics Stock Undervalued?
    The current Cadrenal Therapeutics [CVKD] share price is $12.55. The Score for CVKD is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CVKD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Cadrenal Therapeutics Stock Go Up Next Year?

Data Unavailable

Cadrenal Therapeutics Stock Rating

Data Unavailable

Cadrenal Therapeutics Stock Price History

Is CVKD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVKD is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cadrenal.com

52-Week Data

52-Week High:
32.55
52-Week Low:
5.40

Prediction Charts

Market Cap:
20.82M
Price in USD:
12.55
Volume:
132.66K
Beta:
1.20

Technical Analysis

SMA50:
14.65
SMA100:
11.57
SMA200:
9.52
52-Wk Change:
67%

Stock Predictions

  • Is Cadrenal Therapeutics stock public?
    Yes, Cadrenal Therapeutics is a publicly traded company.
  • What is the Cadrenal Therapeutics stock quote today?
    The Cadrenal Therapeutics stock price is 12.55 USD today.
  • How to buy Cadrenal Therapeutics stock online?
    You can buy Cadrenal Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-21 14.39 14.01 14.99 14.00
Nov-22 14.05 14.99 15.39 14.04
Nov-25 15.28 13.56 15.30 13.13
Nov-26 13.55 13.71 13.99 13.55
Nov-27 14.43 14.15 14.43 13.19
Nov-29 14.50 15.19 15.38 14.03
Dec-2 15.54 15.19 16.22 14.67
Dec-3 14.90 14.01 15.10 13.59
Dec-4 13.81 13.00 13.98 13.00
Dec-5 13.00 13.37 13.76 12.85
Dec-6 13.35 12.55 13.88 12.00
Dec-9 12.55 12.09 12.88 12.00
Dec-10 12.29 12.64 12.99 11.82
Dec-11 12.88 12.55 14.65 12.37

Cadrenal Therapeutics Earnings

Data Unavailable

Cadrenal Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.81 per share, and an increase next year of $3.53 per share.

* Cadrenal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.